AG˹ٷ

STOCK TITAN

[144] Twist Bioscience Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 filing for Twist Bioscience Corporation (TWST) discloses a proposed sale of 292 common shares by insider Paula Green through Fidelity Brokerage Services on or about 06/20/2025. The shares have an aggregate market value of $10,440.37, versus 59,916,141 shares outstanding, representing roughly 0.0005% of the float—an immaterial amount for public investors.

During the preceding three months, the same seller completed five sales totaling 3,017 shares for combined gross proceeds of $104,886.82. All shares being sold were acquired via restricted-stock vesting on 06/18/2025 and are being disposed of for compensation purposes. The filer attests that no undisclosed material adverse information is known.

The filing is routine, signals no change to corporate fundamentals, and appears unlikely to influence TWST’s valuation or liquidity.

La comunicazione del Modulo 144 per Twist Bioscience Corporation (TWST) segnala una proposta di vendita di 292 azioni ordinarie da parte dell’insider Paula Green tramite Fidelity Brokerage Services intorno al 20/06/2025. Le azioni hanno un valore di mercato complessivo di 10.440,37 $, su un totale di 59.916.141 azioni in circolazione, rappresentando circa lo 0,0005% del flottante—una quantità irrilevante per gli investitori pubblici.

Nei tre mesi precedenti, la stessa venditrice ha completato cinque vendite per un totale di 3.017 azioni, con un ricavo lordo complessivo di 104.886,82 $. Tutte le azioni vendute sono state acquisite tramite vesting di azioni vincolate il 18/06/2025 e vengono cedute per motivi di compensazione. Il dichiarante attesta di non essere a conoscenza di informazioni materiali negative non divulgate.

La comunicazione è di routine, non indica cambiamenti nei fondamentali aziendali e sembra improbabile che influenzi la valutazione o la liquidità di TWST.

La presentación del Formulario 144 para Twist Bioscience Corporation (TWST) revela una propuesta de venta de 292 acciones comunes por parte de la insider Paula Green a través de Fidelity Brokerage Services alrededor del 20/06/2025. Las acciones tienen un valor de mercado agregado de $10,440.37, frente a 59,916,141 acciones en circulación, representando aproximadamente el 0.0005% del flotante—una cantidad insignificante para los inversores públicos.

Durante los tres meses previos, la misma vendedora completó cinco ventas que sumaron 3,017 acciones por un total bruto combinado de $104,886.82. Todas las acciones vendidas fueron adquiridas mediante la adquisición condicionada de acciones restringidas el 18/06/2025 y se están vendiendo por motivos de compensación. El declarante certifica que no conoce información material adversa no divulgada.

La presentación es rutinaria, no indica cambios en los fundamentos corporativos y parece improbable que influya en la valoración o liquidez de TWST.

Twist Bioscience Corporation (TWST)� Form 144 제출은 내부� Paula Green가 Fidelity Brokerage Services� 통해 2025� 6� 20일경 292� 일반 주식� 매도� 예정임을 공개합니�. 해당 주식은 � $10,440.37� 시장 가치를 가지�, � 발행 주식 � 59,916,141� � � 0.0005%� 해당하는 미미� 규모입니�.

지� 3개월 동안 동일� 판매자는 5건의 매도� 완료� � 3,017�� 판매했으� � 매출액은 $104,886.82� 달합니다. 매도� 모든 주식은 2025� 6� 18� 제한 주식 권리 확정(vesting)� 통해 취득되었으며 보상 목적으로 처분되고 있습니다. 제출자는 공개되지 않은 중대� 부정적 정보가 없음� 확인합니�.

이번 제출은 일상적인 절차�, 기업� 기본 사항� 변화를 나타내지 않으� TWST� 가� 평가� 유동성에 영향� 미칠 가능성은 낮아 보입니다.

Le dépôt du formulaire 144 pour Twist Bioscience Corporation (TWST) révèle une proposition de vente de 292 actions ordinaires par l’initiée Paula Green via Fidelity Brokerage Services aux alentours du 20/06/2025. Les actions ont une valeur marchande totale de 10 440,37 $, sur un total de 59 916 141 actions en circulation, représentant environ 0,0005 % du flottant—une quantité négligeable pour les investisseurs publics.

Au cours des trois mois précédents, la même vendeuse a réalisé cinq ventes totalisant 3 017 actions pour un produit brut combiné de 104 886,82 $. Toutes les actions vendues ont été acquises par l’acquisition conditionnelle d’actions restreintes le 18/06/2025 et sont cédées à des fins de compensation. Le déclarant atteste qu’aucune information défavorable importante non divulguée n’est connue.

Le dépôt est de routine, ne signale aucun changement dans les fondamentaux de l’entreprise et semble peu susceptible d’influencer la valorisation ou la liquidité de TWST.

Die Einreichung von Formular 144 für Twist Bioscience Corporation (TWST) gibt den geplanten Verkauf von 292 Stammaktien durch Insider Paula Green über Fidelity Brokerage Services um den 20.06.2025 bekannt. Die Aktien haben einen Gesamtmarktwert von 10.440,37 $ bei 59.916.141 ausstehenden Aktien, was etwa 0,0005 % des Streubesitzes entspricht � ein unbedeutender Betrag für öffentliche Investoren.

In den vorangegangenen drei Monaten hat dieselbe Verkäuferin fünf Verkäufe mit insgesamt 3.017 Aktien abgeschlossen, die einen Bruttoerlös von 104.886,82 $ einbrachten. Alle zu verkaufenden Aktien wurden am 18.06.2025 durch Restricted-Stock-Vesting erworben und werden aus Vergütungsgründen veräußert. Der Einreicher bestätigt, dass keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.

Die Einreichung ist routinemäßig, signalisiert keine Änderung der Unternehmensgrundlagen und wird voraussichtlich keinen Einfluss auf die Bewertung oder Liquidität von TWST haben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor insider sale (292 shares) vs. 59.9 M float; neutral impact.

This Form 144 shows Paula Green’s intent to sell 292 shares (~$10.4 k). Even combined with the prior 3,017 shares sold since March, the total disposal of 3,309 shares equals about 0.006% of outstanding stock—statistically insignificant. The shares stem from recent restricted-stock vesting, a common liquidity event rather than an indicator of strategic concern. No red flags (e.g., clustered executive selling, large percentages, or adverse disclosures) accompany the notice. I therefore classify the market impact as neutral; most institutional investors will disregard it.

La comunicazione del Modulo 144 per Twist Bioscience Corporation (TWST) segnala una proposta di vendita di 292 azioni ordinarie da parte dell’insider Paula Green tramite Fidelity Brokerage Services intorno al 20/06/2025. Le azioni hanno un valore di mercato complessivo di 10.440,37 $, su un totale di 59.916.141 azioni in circolazione, rappresentando circa lo 0,0005% del flottante—una quantità irrilevante per gli investitori pubblici.

Nei tre mesi precedenti, la stessa venditrice ha completato cinque vendite per un totale di 3.017 azioni, con un ricavo lordo complessivo di 104.886,82 $. Tutte le azioni vendute sono state acquisite tramite vesting di azioni vincolate il 18/06/2025 e vengono cedute per motivi di compensazione. Il dichiarante attesta di non essere a conoscenza di informazioni materiali negative non divulgate.

La comunicazione è di routine, non indica cambiamenti nei fondamentali aziendali e sembra improbabile che influenzi la valutazione o la liquidità di TWST.

La presentación del Formulario 144 para Twist Bioscience Corporation (TWST) revela una propuesta de venta de 292 acciones comunes por parte de la insider Paula Green a través de Fidelity Brokerage Services alrededor del 20/06/2025. Las acciones tienen un valor de mercado agregado de $10,440.37, frente a 59,916,141 acciones en circulación, representando aproximadamente el 0.0005% del flotante—una cantidad insignificante para los inversores públicos.

Durante los tres meses previos, la misma vendedora completó cinco ventas que sumaron 3,017 acciones por un total bruto combinado de $104,886.82. Todas las acciones vendidas fueron adquiridas mediante la adquisición condicionada de acciones restringidas el 18/06/2025 y se están vendiendo por motivos de compensación. El declarante certifica que no conoce información material adversa no divulgada.

La presentación es rutinaria, no indica cambios en los fundamentos corporativos y parece improbable que influya en la valoración o liquidez de TWST.

Twist Bioscience Corporation (TWST)� Form 144 제출은 내부� Paula Green가 Fidelity Brokerage Services� 통해 2025� 6� 20일경 292� 일반 주식� 매도� 예정임을 공개합니�. 해당 주식은 � $10,440.37� 시장 가치를 가지�, � 발행 주식 � 59,916,141� � � 0.0005%� 해당하는 미미� 규모입니�.

지� 3개월 동안 동일� 판매자는 5건의 매도� 완료� � 3,017�� 판매했으� � 매출액은 $104,886.82� 달합니다. 매도� 모든 주식은 2025� 6� 18� 제한 주식 권리 확정(vesting)� 통해 취득되었으며 보상 목적으로 처분되고 있습니다. 제출자는 공개되지 않은 중대� 부정적 정보가 없음� 확인합니�.

이번 제출은 일상적인 절차�, 기업� 기본 사항� 변화를 나타내지 않으� TWST� 가� 평가� 유동성에 영향� 미칠 가능성은 낮아 보입니다.

Le dépôt du formulaire 144 pour Twist Bioscience Corporation (TWST) révèle une proposition de vente de 292 actions ordinaires par l’initiée Paula Green via Fidelity Brokerage Services aux alentours du 20/06/2025. Les actions ont une valeur marchande totale de 10 440,37 $, sur un total de 59 916 141 actions en circulation, représentant environ 0,0005 % du flottant—une quantité négligeable pour les investisseurs publics.

Au cours des trois mois précédents, la même vendeuse a réalisé cinq ventes totalisant 3 017 actions pour un produit brut combiné de 104 886,82 $. Toutes les actions vendues ont été acquises par l’acquisition conditionnelle d’actions restreintes le 18/06/2025 et sont cédées à des fins de compensation. Le déclarant atteste qu’aucune information défavorable importante non divulguée n’est connue.

Le dépôt est de routine, ne signale aucun changement dans les fondamentaux de l’entreprise et semble peu susceptible d’influencer la valorisation ou la liquidité de TWST.

Die Einreichung von Formular 144 für Twist Bioscience Corporation (TWST) gibt den geplanten Verkauf von 292 Stammaktien durch Insider Paula Green über Fidelity Brokerage Services um den 20.06.2025 bekannt. Die Aktien haben einen Gesamtmarktwert von 10.440,37 $ bei 59.916.141 ausstehenden Aktien, was etwa 0,0005 % des Streubesitzes entspricht � ein unbedeutender Betrag für öffentliche Investoren.

In den vorangegangenen drei Monaten hat dieselbe Verkäuferin fünf Verkäufe mit insgesamt 3.017 Aktien abgeschlossen, die einen Bruttoerlös von 104.886,82 $ einbrachten. Alle zu verkaufenden Aktien wurden am 18.06.2025 durch Restricted-Stock-Vesting erworben und werden aus Vergütungsgründen veräußert. Der Einreicher bestätigt, dass keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.

Die Einreichung ist routinemäßig, signalisiert keine Änderung der Unternehmensgrundlagen und wird voraussichtlich keinen Einfluss auf die Bewertung oder Liquidität von TWST haben.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many TWST shares are being sold under this Form 144?

The notice covers 292 common shares of Twist Bioscience.

What is the aggregate market value of the shares to be sold?

The 292 shares are valued at $10,440.37 in total.

Who is the seller in Twist Bioscience’s Form 144 filing?

The seller is Paula Green, whose address is listed in South San Francisco, CA.

When is the planned sale date for the TWST shares?

The approximate sale date provided is 06/20/2025.

What percentage of Twist Bioscience’s outstanding shares does the sale represent?

The 292 shares equal roughly 0.0005% of the 59,916,141 shares outstanding.

Have there been other recent sales by the same insider?

Yes. Over the last three months, the insider sold 3,017 shares for $104,886.82 in gross proceeds.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

1.55B
59.18M
1.88%
116.74%
17.29%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
United States
SOUTH SAN FRANCISCO